Biologics Discovery and Development
Exponential power to transform drug discovery.
One ecosystem. Three forces: AI, Data, Advanced Lab Research.
A fundamental shift in biologics discovery
By uniting AI, data, and advanced lab research into an integrated ecosystem, we support deeper biological insight and connected evidence—enabling diversity, scale, and specificity as programs move forward. Your success is our success.
A comprehensive biontelligence ecosystem
Discovery no longer follows a single linear path. Advantage now comes from adaptability and a high-throughput ecosystem that connects every facet of R&D. As AI makes discovery more fluid, researchers can surround their targets in new ways to explore biological evidence, refine hypotheses, and advance promising candidates with greater precision and efficiency.
Customized biologics discovery R&D path
The biologics path is wide—spanning therapeutic, anti-drug and diagnostic antibodies, peptide-based therapies, vaccines and beyond. It’s a path that demands versatility, scale, and the power to adapt with every program.
Customized technologies
Transformation starts here, tackling complex challenges across the industry and within your program. More than tools. More than technology. AI, data, and lab capabilities working together in a flexible combination designed to fit your needs.
Therapeutic Antibodies
Transformative workflows driving discovery success.
Anti-Drug Antibodies
High success. High reliability. High client retention.
Diagnostic Antibodies
Performance and scale for precision detection.
Peptide Therapeutics
Unlocking new opportunities through peptide discovery.
Vaccine Discovery
Power to uncover rare insights for faster discovery.
Bio-native AI
Biological reasoning at scale to explore, refine, generate and accelerate.
Data Integration
Unified insights across sequence, structure, and function.
Advanced Lab Research
Demonstrated success driving diverse discovery breakthroughs.
Customized biologics discovery R&D path
The biologics path is wide—spanning therapeutic, anti-drug and diagnostic antibodies, peptide-based therapies, vaccines and beyond. It’s a path that demands versatility, scale, and the power to adapt with every program.
Therapeutic Antibodies
Transformative workflows driving discovery success.
Anti-Drug Antibodies
High success. High reliability. High client retention.
Diagnostic Antibodies
Performance and scale for precision detection.
Peptide Therapeutics
Unlocking new opportunities through peptide discovery.
Vaccine Discovery
Power to uncover rare insights for faster discovery.
Customized technologies
Transformation starts here, tackling complex challenges across the industry and within your program. More than tools. More than technology. AI, data, and lab capabilities working together in a flexible combination designed to fit your needs.
Bio-native AI
Biological reasoning at scale to explore, refine, generate and accelerate.
Data Integration
Unified insights across sequence, structure, and function.
Advanced Lab Research
Demonstrated success driving diverse discovery breakthroughs.
Designed with the market in mind.
Built for challenges.
Committed to redefining what’s possible in biologics discovery.
Science. Technology. Rigor.
Expertise matters
Deep expertise in science and technology, applied strategically to guide programs and product development in support of discovery success.
3X
faster
Speed matters
Up to 3X faster from data to discovery.
Early stage
de-risking
Safety matters
Early-stage de-risking. AI and lab research converge to identify potential risks, refine candidates, and support stronger downstream outcomes.
>98%
success rate
Success matters
Greater than 98% discovery success* with leading B cell technology, supporting 15+ molecules advanced to the clinic.
* “Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Take the first step
Let’s expand what’s possible for human health.
Spotlight
CaseXCase™: LensAI case study series
A collection of the latest results highlighting how new approaches are shaping modern discovery.
Four ways to access MindWalk
We build it
Customizable offerings in biologics discovery—from target analysis to optimized leads.
You build it
Access to state-of-the-art LensAI SaaS platform.
The Vault
Smarter starts: a portfolio of partner-ready assets.
Partnership
We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.






